Speech-Language Therapy for Aphasia
(TERRA Trial)
Trial Summary
The trial information does not specify whether you need to stop taking your current medications.
Research shows that phonologically-focused therapy, like Phonological Components Analysis (PCA), can significantly improve naming abilities in people with aphasia, with many maintaining improvements over time. Additionally, phonological treatments may be particularly beneficial for individuals with more severe impairments and apraxia of speech, while semantic treatments might be more effective for those with milder impairments and fluent speech.
12345The research does not report any safety concerns for speech-language therapy methods like Phonological Cueing Treatment (PCT) and Semantic Feature Analysis (SFA) in people with aphasia, suggesting these treatments are generally safe for humans.
13456This treatment is unique because it combines phonologically-focused tasks, which help with sound retrieval, and semantically-focused tasks, which aid in understanding word meanings, to improve naming abilities in people with aphasia. It is tailored to individual needs, with phonological tasks benefiting those with severe impairments and apraxia of speech, while semantic tasks are more effective for those with milder impairments and fluent speech.
23678Eligibility Criteria
This trial is for English-speaking adults aged 21-80 who've had a left hemisphere stroke at least a year ago and can consent to treatment. They must be MRI compatible without metal implants or claustrophobia, and have no history of other brain diseases or severe speech/comprehension impairments.Inclusion Criteria
Exclusion Criteria
Trial Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive 3 weeks of daily semantically-focused treatment and 3 weeks of daily phonologically-focused treatment, either remotely or in-clinic
Follow-up
Participants are monitored for changes in speech production and quality of life after treatment